Brief: Chiome Bioscience to receive patent in New Zealand
20/12/2016 06:18
Dec 20 (Reuters) - Chiome Bioscience Inc 4583.T :
* Says it to receive patent in New Zealand for ANTI-HUMAN
TROP-2 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO
Source text in Japanese: https://goo.gl/RqXNRJ
Further company Coverage: 4583.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))